ANKRD49 and metastatic malignant neoplasm in the lymph nodes: Our Cox modelling also suggested that high level of ANKRD49 expression may be used as an independent prognostic factor for patients with LUAD and their rate of survival, in particular at advanced disease stages, including TNM stage (III‐IV), lymph node metastasis, and differentiation.